ARKG peer analysis
ARK Genomic Revolution (ARKG) against its competitors: price, today's move, 1-year return and market value side by side.
ARKG and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| DFIP Dimensional Inflation-Protected Securities ETF | $40.03 | 0.35% | -4.94% | – |
| FMAY US Equity Buffer May | $57.05 | -0.38% | 8.43% | – |
| IYE iShares US Energy | $71.27 | -3.45% | 53.36% | – |
| PAUG US Equity Buffer | $46.56 | -1.00% | 8.51% | – |
| PSC Principal Small-Cap | $68.37 | -1.67% | 21.20% | – |
| QDTE Nasdaq 100 0DTE | $26.67 | -1.04% | -25.57% | – |
| RWK MidCap 400 Revenue | $143.63 | -0.19% | 14.51% | – |
| TMSL Small-Mid Cap | $41.67 | -1.37% | 18.35% | – |
| YINN China Bull 3X | $22.59 | 3.67% | -54.03% | – |
| ARKG ARK Genomic Revolution | $48.41 | -5.82% | 62.50% | – |
- ARKG's peers: DFIP (Dimensional Inflation-Protected Securities ETF), FMAY (US Equity Buffer May), IYE (iShares US Energy), PAUG (US Equity Buffer), PSC (Principal Small-Cap), QDTE (Nasdaq 100 0DTE), RWK (MidCap 400 Revenue), TMSL (Small-Mid Cap).
Updated 2026-11-02 20:39 UTC